Evidence map›Paper›PMID 29989925›Full record

ArticleIEEE transactions on bio-medical engineering2018

Extremum Seeking Control for Personalized Zone Adaptation in Model Predictive Control for Type 1 Diabetes.

Zhixing Cao, Ravi Gondhalekar, Eyal Dassau, Francis J Doyle

Abstract read
In one paragraph

Article in IEEE transactions on bio-medical engineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance.Automatica : the journal of IFAC, the International Federation of Automatic Control · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhixing Cao
Ravi Gondhalekar
Eyal Dassau
Francis J Doyle

Funding

Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) TrialUC4DK108483 · NIDDK · UNIVERSITY OF VIRGINIA · PI ANDERSON, STACEY, DOYLE, FRANCIS J · 2016 to 2016
$12.7M
Ambulatory Artificial Pancreas: merging physiology, behavior, and control designDP3DK094331 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI BASU, ANANDA, DOYLE, FRANCIS J · 2011 to 2014
$4.6M
Pediatric Artificial Pancreas System for Enhanced Diabetes Management in Young Children with Type 1 DiabetesDP3DK104057 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI DASSAU, EYAL, DOYLE, FRANCIS J · 2014 to 2014
$1.8M
NIDDK NIH HHS DP3 DK094331NIDDK NIH HHS DP3 DK104057NIDDK NIH HHS UC4 DK108483
6 · The paper itself

Abstract

Zone model predictive control has proven to be an effective closed-loop method to regulate blood glucose for people with type 1 diabetes (T1D). In this paper, we present a universal model-free optimization scheme for adapting the zone for T1D patients individually. The adaptation is based on a clinical glycemic risk index named relative regularized glycemic penalty index (rrGPI), which is calculated from glucose measurements by a continuous glucose monitor. The scheme's objective is to minimize rrGPI by simultaneously modulating a controller's blood glucose target zone's upper bound and lower bound. The adaptation mechanism is based on extremum seeking control, in which the zone boundaries are driven by gradient estimation obtained by continuously sinusoidally modulating and demodulating the rrGPI readings. To improve the adaptation method's robustness against uncertainties, a decaying feedback gain and a vanishing dither signal are employed. in-silico trials suggested that the personalized optimized zone can be reached within a week of adaptation. Both for announced and unannounced meals, the proposed method outperforms the fixed zone [80, 140] mg/dL, which has been employed in the authors' clinical trials. It is also shown that the developed method has strong robustness against real-life uncertainties.

Indexed as

Insulin Infusion SystemsSignal Processing, Computer-AssistedBlood GlucoseBlood Glucose Self-MonitoringComputer SimulationDiabetes Mellitus, Type 1HumansInsulinBlood GlucoseInsulin

Identifiers

PMID29989925
PMCPMC6760655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.